New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 6, 2014
06:01 EDTACORAcorda Therapeutics downgraded to Neutral from Buy at Citigroup
Citigroup downgraded Acorda Therapeutics citing a lack of near-term catalysts and lowered its price target for shares to $33 from $37.
News For ACOR From The Last 14 Days
Check below for free stories on ACOR the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for ACOR

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use